371 related articles for article (PubMed ID: 33334821)
1. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
2. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT; Kaiser AM; Morgens DW; Boutelle AM; Seoane JA; Van Nostrand EL; Zhu C; Houlihan SL; Mello SS; Yee BA; McClendon J; Pierce SE; Winters IP; Wang M; Connolly AJ; Lowe SW; Curtis C; Yeo GW; Winslow MM; Bassik MC; Attardi LD
Mol Cell; 2020 Nov; 80(3):452-469.e9. PubMed ID: 33157015
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
4. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer.
Matsumoto Y; Itou J; Sato F; Toi M
Cancer Med; 2018 Feb; 7(2):454-462. PubMed ID: 29356399
[TBL] [Abstract][Full Text] [Related]
5. The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells.
Novosad VO; Maltseva DV
Bull Exp Biol Med; 2023 May; 175(1):144-149. PubMed ID: 37336810
[TBL] [Abstract][Full Text] [Related]
6. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.
Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ
J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190
[TBL] [Abstract][Full Text] [Related]
7. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.
Yae T; Tsuchihashi K; Ishimoto T; Motohara T; Yoshikawa M; Yoshida GJ; Wada T; Masuko T; Mogushi K; Tanaka H; Osawa T; Kanki Y; Minami T; Aburatani H; Ohmura M; Kubo A; Suematsu M; Takahashi K; Saya H; Nagano O
Nat Commun; 2012 Jun; 3():883. PubMed ID: 22673910
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.
Cappellari M; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Saarikettu J; Silvennoinen O; Sette C
Oncogene; 2014 Jul; 33(29):3794-802. PubMed ID: 23995791
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis.
Liu B; Song A; Gui P; Wang J; Pan Y; Li C; Li S; Zhang Y; Jiang T; Xu Y; Pei D; Song J
Cell Death Dis; 2023 Jul; 14(7):427. PubMed ID: 37452042
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.
David G; Reboutier D; Deschamps S; Méreau A; Taylor W; Padilla-Parra S; Tramier M; Audic Y; Paillard L
Biochem Biophys Res Commun; 2022 Oct; 626():79-84. PubMed ID: 35973378
[TBL] [Abstract][Full Text] [Related]
13. Nuclear hyaluronidase 2 drives alternative splicing of
Midgley AC; Oltean S; Hascall V; Woods EL; Steadman R; Phillips AO; Meran S
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162741
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
[TBL] [Abstract][Full Text] [Related]
15. RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.
Sohr S; Engeland K
Cell Cycle; 2008 Nov; 7(21):3448-60. PubMed ID: 18971636
[TBL] [Abstract][Full Text] [Related]
16. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
Filippov V; Filippova M; Duerksen-Hughes PJ
Cancer Res; 2007 Aug; 67(16):7621-30. PubMed ID: 17699766
[TBL] [Abstract][Full Text] [Related]
17. Identification of Significant RNA-Binding Proteins in the Process of CD44 Splicing Using the Boosted Beta Regression Algorithm.
Novosad VO
Dokl Biochem Biophys; 2023 Jun; 510(1):99-103. PubMed ID: 37582871
[TBL] [Abstract][Full Text] [Related]
18. TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms.
Guo L; Ke H; Zhang H; Zou L; Yang Q; Lu X; Zhao L; Jiao B
Cell Death Dis; 2022 May; 13(5):428. PubMed ID: 35504883
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status.
Zeilstra J; Joosten SP; Vermeulen L; Koster J; Medema JP; Versteeg R; Spaargaren M; Pals ST
PLoS One; 2013; 8(8):e72849. PubMed ID: 24009708
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
